These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19912688)
1. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR]. Zhao Y; Jia HL; Zhou HJ; Dong QZ; Fu LY; Yan ZW; Sun J; Ren N; Ye QH; Qin LX Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):526-30. PubMed ID: 19912688 [TBL] [Abstract][Full Text] [Related]
2. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. Zhou J; Wang W J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032 [TBL] [Abstract][Full Text] [Related]
3. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma]. Li Q; Wang G; Zhang ZM Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010 [TBL] [Abstract][Full Text] [Related]
5. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664 [TBL] [Abstract][Full Text] [Related]
6. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Fan Q; He M; Deng X; Wu WK; Zhao L; Tang J; Wen G; Sun X; Liu Y Cell Biochem Funct; 2013 Jun; 31(4):319-24. PubMed ID: 23001723 [TBL] [Abstract][Full Text] [Related]
7. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884 [TBL] [Abstract][Full Text] [Related]
8. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643 [TBL] [Abstract][Full Text] [Related]
9. [Construction and identification of the human liver-specific miR-122 expression vector]. Huang Z; Liu C Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):587-90. PubMed ID: 19637636 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
12. [Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR]. Liu ZR; Chen XW; Qiao XH; Wang R; Xiang Z Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):751-3. PubMed ID: 19403413 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476 [TBL] [Abstract][Full Text] [Related]
14. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222 [TBL] [Abstract][Full Text] [Related]
15. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101 [TBL] [Abstract][Full Text] [Related]
18. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648 [TBL] [Abstract][Full Text] [Related]
19. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]